i-SENS, Inc. (KOSDAQ:099190)
16,880
+60 (0.36%)
Jun 10, 2026, 3:30 PM KST
i-SENS Revenue
i-SENS had revenue of 75.13B KRW in the quarter ending March 31, 2026, a decrease of -1.49%. This brings the company's revenue in the last twelve months to 314.31B, up 5.12% year-over-year. In the year 2025, i-SENS had annual revenue of 315.44B with 8.35% growth.
Revenue (ttm)
314.31B
Revenue Growth
+5.12%
P/S Ratio
1.54
Revenue / Employee
354.35M
Employees
887
Market Cap
485.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 315.44B | 24.31B | 8.35% |
| Dec 31, 2024 | 291.14B | 26.02B | 9.81% |
| Dec 31, 2023 | 265.12B | 283.13M | 0.11% |
| Dec 31, 2022 | 264.84B | 31.90B | 13.70% |
| Dec 31, 2021 | 232.93B | 29.23B | 14.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seegene | 487.37B |
| InBody Co.,Ltd | 246.81B |
| WON TECH | 159.67B |
| DRTECH | 122.78B |
| L&C BIO Co.,LTD | 98.10B |
| Bio Plus | 94.42B |
| LabGenomics | 84.19B |
| SEERS | 76.63B |